Cargando…
RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679969/ https://www.ncbi.nlm.nih.gov/pubmed/38009403 http://dx.doi.org/10.1002/ctm2.1484 |
| _version_ | 1785150644918681600 |
|---|---|
| author | Watts, Gerald F. Chan, Dick C. |
| author_facet | Watts, Gerald F. Chan, Dick C. |
| author_sort | Watts, Gerald F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10679969 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106799692023-11-27 RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study Watts, Gerald F. Chan, Dick C. Clin Transl Med Commentary John Wiley and Sons Inc. 2023-11-27 /pmc/articles/PMC10679969/ /pubmed/38009403 http://dx.doi.org/10.1002/ctm2.1484 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Watts, Gerald F. Chan, Dick C. RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title | RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title_full | RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title_fullStr | RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title_full_unstemmed | RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title_short | RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study |
| title_sort | rna interference therapy for targeting angptl3 and atherogenic lipoproteins: findings and implications of a recent phase i study |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679969/ https://www.ncbi.nlm.nih.gov/pubmed/38009403 http://dx.doi.org/10.1002/ctm2.1484 |
| work_keys_str_mv | AT wattsgeraldf rnainterferencetherapyfortargetingangptl3andatherogeniclipoproteinsfindingsandimplicationsofarecentphaseistudy AT chandickc rnainterferencetherapyfortargetingangptl3andatherogeniclipoproteinsfindingsandimplicationsofarecentphaseistudy |